What does the evidence say about Omega 3 Mood Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Omega 3 Mood Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Effects of omega-3 PUFA-enriched egg consumption on metabolic parameters in elderly adults with metabolic syndrome: study protocol for a randomized controlled trial [Yang H (2026); evidence level 2] - Mechanistic evidence implicates neuroimmune activation, inflammation, altered neurotransmitter synthesis, and microbiota-derived metabolites. [Hachmeriyan A (2026); evidence level 4] - Objective: The objective of this study is to synthesize evidence on omega-3 polyunsaturated fatty acids ( n -3 PUFAs), the microbiota-gut-brain axis, and vitamins and minerals that influence neurotransmitter synthesis, inflammation, and brain function and to translate these findings into food-based strategies. [Hachmeriyan A (2026); evidence level 4] - Results: RCT and meta-analytic evidence suggest modest benefits of omega-3 supplementation for anxiety severity and depressive symptoms, with heterogeneity by dose, EPA: DHA composition, and baseline inflammatory status. [Hachmeriyan A (2026); evidence level 4] - Background: Nutritional psychiatry increasingly links diet quality and specific bioactive nutrients to depression and anxiety outcomes. [Hachmeriyan A (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.